UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 100

Sortiert nach

B-Aggressive Lymphoma (BAL) Family Proteins Have Unique Domains Which Modulate Transcription and Exhibit PARP Activity

Blood, 2005-11, Vol.106 (11), p.2400-2400

2005

Volltextzugriff (PDF)

The Expression of SREBF1 Inducing By Dexamethasone Promotes Bone Marrow Mesenchymal Stromal Cells Differentiate to Adipocytes to Attract and Protect the Residual T-Cell Acute Lymphoblastic Leukemia Cells

Blood, 2022-11, Vol.140 (Supplement 1), p.11434-11434

2022

Volltextzugriff (PDF)

NK Cells Suppress Hyperfunction of CTLs Via ATM-Mediated NKG2D/NKG2DLs Activation in Severe Aplastic Anemia

Blood, 2022-11, Vol.140 (Supplement 1), p.2933-2934

2022

Volltextzugriff (PDF)

Profiling Immune Cells in DLBCL Patients with Mass Cytometry By Time-of-Flight (CyTOF)

Blood, 2022-11, Vol.140 (Supplement 1), p.3591-3592

2022

Volltextzugriff (PDF)

The Efficacy of a Novel Oral Proteasome Inhibitor NNU546 in Multiple Myeloma

Blood, 2019-11, Vol.134 (Supplement_1), p.5586-5586

2019

Volltextzugriff (PDF)

RFWD2 Induces Cellular Proliferation and Proteasome Inhibitor Resistance By Mediating p27 Ubiqutinaiton in Multiple Myeloma

Blood, 2019-11, Vol.134 (Supplement_1), p.3068-3068

2019

Volltextzugriff (PDF)

CHEK1 and circCHEK1_246aa Promote Multiple Myeloma Malignancy By Evoking Chromosomal Instability and Bone Lesion

Blood, 2020-11, Vol.136 (Supplement 1), p.9-10

2020

Volltextzugriff (PDF)

The Publication Trends and Hotspots of Multiple Myeloma Research from 2010 to 2019: A 10-Year Bibliometric Analysis

Blood, 2022-11, Vol.140 (Supplement 1), p.12544-12544

2022

Volltextzugriff (PDF)

Chidamide with Azacitidine and CHOP Treatment Plus Autologous Transplantation, Followed By Maintenance with Chidamide for Patients with Newly Diagnosed Peripheral T-Cell Lymphoma (PTCL): Interim Analysis of a Prospective,Single Center, Single-Arm, Phase 2 Trial

Blood, 2022-11, Vol.140 (Supplement 1), p.12010-12010

2022

Volltextzugriff (PDF)

High Expression of Plasma IL-1β Levels and Transition of Regulatory T-Cell Subsets Correlate with Disease Progression in Myelodysplastic Syndrome

Blood, 2022-11, Vol.140 (Supplement 1), p.9761-9762

2022

Volltextzugriff (PDF)

Exploration of the Therapeutic Effects of CD47 and CD38 Antibody Combination in Relapsed or Refractory Multiple Myeloma (rrMM) and the Correlation with CD47 and CD38 Expression

Blood, 2022-11, Vol.140 (Supplement 1), p.9937-9938

2022

Volltextzugriff (PDF)

Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease

Blood, 2008-09, Vol.112 (5), p.2101-2110

2008

Volltextzugriff (PDF)

Pyruvate Kinase M2 Regulates Hif-1alpha Activity in Myeloid Dendritic Cells from Patients with Severe Aplastic Anemia

Blood, 2021-11, Vol.138 (Supplement 1), p.1109-1109

2021

Volltextzugriff (PDF)

Serum Level of IFN-a2 and Regulatory T-Cell Subsets Correlates with Disease Progression in De Novo Myelodysplastic Syndrome

Blood, 2021-11, Vol.138 (Supplement 1), p.3671-3671

2021

Volltextzugriff (PDF)

The Role of TLR4 Inducing Macrophage Pyroptosis in the Pathogenesis of Severe Aplastic Anemia

Blood, 2021-11, Vol.138 (Supplement 1), p.1114-1114

2021

Volltextzugriff (PDF)

Developing CD70-Targeted CAR-T Cells for the Treatment of Hematological and Solid Malignancies

Blood, 2022-11, Vol.140 (Supplement 1), p.12695-12695

2022

Volltextzugriff (PDF)

In vivo–activated CD103+CD4+ regulatory T cells ameliorate ongoing chronic graft-versus-host disease

Blood, 2008-09, Vol.112 (5), p.2129-2138

2008

Volltextzugriff (PDF)

Preliminary Results from the Launch Study-a Multicenter, Open-Label Study of Selinexor, Dexamethasone and Chemotherapy Drugs in Relapsed/ Refractory Multiple Myeloma

Blood, 2022-11, Vol.140 (Supplement 1), p.12613-12613

2022

Volltextzugriff (PDF)

High Mutational Burden of Chromatin-Modifying Genes Defines a Relatively Indolent Subgroup of Plasma Cell Dyscrasias

Blood, 2022-11, Vol.140 (Supplement 1), p.12452-12453

2022

Volltextzugriff (PDF)

The Effect of Pyruvate Kinase M2: Inhibitor(shikonin) on the Function of Mdc in Severe Aplastic Anemia Mouse Model

Blood, 2019-11, Vol.134 (Supplement_1), p.5021-5021

2019

Volltextzugriff (PDF)

The Role of PKM2 in the Activation of Myeloid Dendritic Cells from Patients with Severe Aplastic Anemia

Blood, 2016-12, Vol.128 (22), p.1497-1497

2016

Volltextzugriff (PDF)

FOXM1, CDK6 and Rb Dependent Drug Resistance and Senescence in Myeloma

Blood, 2016-12, Vol.128 (22), p.4456-4456

2016

Volltextzugriff (PDF)

MiR-221/222 Promote Dexamethasone Resistance of Multiple Myeloma through Inhibition of Autophagy By Targeting ATG12

Blood, 2018-11, Vol.132 (Supplement 1), p.4469-4469

2018

Volltextzugriff (PDF)

Clinical Characteristics of Hemophagocytic Syndrome: 46 Cases Report and Literature Re-View

Blood, 2018-11, Vol.132 (Supplement 1), p.5916-5916

2018

Volltextzugriff (PDF)

The Platelet Isoform of Phosphofructokinase in Acute Myeloid Leukemia: Clinical Relevance and Prognostic Implication

Blood, 2018-11, Vol.132 (Supplement 1), p.5251-5251

2018

Volltextzugriff (PDF)

1 – 25 von 100

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieThe Faseb Journal

SpracheSlowakisch

Zeitschrift / SerieBlood

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(100)

Publikationsform

Artikel
(100)

Sprache

Englisch
(100)
Japanisch
(3)

Erscheinungsjahr

n.n

Kollektion

Menü

Weitere Dienste

Einstellungen

B-Aggressive Lymphoma (BAL) Family Proteins Have Unique Domains Which Modulate Transcription and Exhibit PARP Activity

The Expression of SREBF1 Inducing By Dexamethasone Promotes Bone Marrow Mesenchymal Stromal Cells Differentiate to Adipocytes to Attract and Protect the Residual T-Cell Acute Lymphoblastic Leukemia Cells

NK Cells Suppress Hyperfunction of CTLs Via ATM-Mediated NKG2D/NKG2DLs Activation in Severe Aplastic Anemia

Profiling Immune Cells in DLBCL Patients with Mass Cytometry By Time-of-Flight (CyTOF)

The Efficacy of a Novel Oral Proteasome Inhibitor NNU546 in Multiple Myeloma

RFWD2 Induces Cellular Proliferation and Proteasome Inhibitor Resistance By Mediating p27 Ubiqutinaiton in Multiple Myeloma

CHEK1 and circCHEK1_246aa Promote Multiple Myeloma Malignancy By Evoking Chromosomal Instability and Bone Lesion

The Publication Trends and Hotspots of Multiple Myeloma Research from 2010 to 2019: A 10-Year Bibliometric Analysis

Chidamide with Azacitidine and CHOP Treatment Plus Autologous Transplantation, Followed By Maintenance with Chidamide for Patients with Newly Diagnosed Peripheral T-Cell Lymphoma (PTCL): Interim Analysis of a Prospective,Single Center, Single-Arm, Phase 2 Trial

High Expression of Plasma IL-1β Levels and Transition of Regulatory T-Cell Subsets Correlate with Disease Progression in Myelodysplastic Syndrome

Exploration of the Therapeutic Effects of CD47 and CD38 Antibody Combination in Relapsed or Refractory Multiple Myeloma (rrMM) and the Correlation with CD47 and CD38 Expression

Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease

Pyruvate Kinase M2 Regulates Hif-1alpha Activity in Myeloid Dendritic Cells from Patients with Severe Aplastic Anemia

Serum Level of IFN-a2 and Regulatory T-Cell Subsets Correlates with Disease Progression in De Novo Myelodysplastic Syndrome

The Role of TLR4 Inducing Macrophage Pyroptosis in the Pathogenesis of Severe Aplastic Anemia

Developing CD70-Targeted CAR-T Cells for the Treatment of Hematological and Solid Malignancies

In vivo–activated CD103+CD4+ regulatory T cells ameliorate ongoing chronic graft-versus-host disease

Preliminary Results from the Launch Study-a Multicenter, Open-Label Study of Selinexor, Dexamethasone and Chemotherapy Drugs in Relapsed/ Refractory Multiple Myeloma

High Mutational Burden of Chromatin-Modifying Genes Defines a Relatively Indolent Subgroup of Plasma Cell Dyscrasias

The Effect of Pyruvate Kinase M2: Inhibitor(shikonin) on the Function of Mdc in Severe Aplastic Anemia Mouse Model

The Role of PKM2 in the Activation of Myeloid Dendritic Cells from Patients with Severe Aplastic Anemia

FOXM1, CDK6 and Rb Dependent Drug Resistance and Senescence in Myeloma

MiR-221/222 Promote Dexamethasone Resistance of Multiple Myeloma through Inhibition of Autophagy By Targeting ATG12

Clinical Characteristics of Hemophagocytic Syndrome: 46 Cases Report and Literature Re-View

The Platelet Isoform of Phosphofructokinase in Acute Myeloid Leukemia: Clinical Relevance and Prognostic Implication

Aktive Filter

Suchergebnisse filtern